ASX - By Stock
|
RAC |
Re:
Ann: Appendix 3Y - Dr Daniel Tillett
|
|
virtuozi
|
43 |
16K |
18 |
07/10/22 |
07/10/22 |
ASX - By Stock
|
43
|
16K
|
18
|
|
ASX - By Stock
|
RAC |
Re:
RAC media coverage
|
|
virtuozi
|
2.2K |
742K |
9 |
28/09/22 |
28/09/22 |
ASX - By Stock
|
2.2K
|
742K
|
9
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
virtuozi
|
21K |
7.3M |
17 |
23/09/22 |
23/09/22 |
ASX - By Stock
|
21K
|
7.3M
|
17
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
virtuozi
|
21K |
7.3M |
9 |
02/08/22 |
02/08/22 |
ASX - By Stock
|
21K
|
7.3M
|
9
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
virtuozi
|
21K |
7.3M |
13 |
01/08/22 |
01/08/22 |
ASX - By Stock
|
21K
|
7.3M
|
13
|
|
ASX - By Stock
|
RAC |
Re:
RAC media coverage
|
|
virtuozi
|
2.2K |
742K |
23 |
28/07/22 |
28/07/22 |
ASX - By Stock
|
2.2K
|
742K
|
23
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Quarterly Activity Report & Appendix 4C
|
|
virtuozi
|
48 |
15K |
14 |
25/07/22 |
25/07/22 |
ASX - By Stock
|
48
|
15K
|
14
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race investor briefing invitation
|
|
virtuozi
|
28 |
11K |
5 |
25/07/22 |
25/07/22 |
ASX - By Stock
|
28
|
11K
|
5
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race investor briefing invitation
|
|
virtuozi
|
28 |
11K |
15 |
25/07/22 |
25/07/22 |
ASX - By Stock
|
28
|
11K
|
15
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race investor briefing invitation
|
|
virtuozi
|
28 |
11K |
26 |
25/07/22 |
25/07/22 |
ASX - By Stock
|
28
|
11K
|
26
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
virtuozi
|
11K |
3.8M |
32 |
06/07/22 |
06/07/22 |
General
|
11K
|
3.8M
|
32
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
virtuozi
|
21K |
7.3M |
3 |
05/07/22 |
05/07/22 |
ASX - By Stock
|
21K
|
7.3M
|
3
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
virtuozi
|
21K |
7.3M |
53 |
05/07/22 |
05/07/22 |
ASX - By Stock
|
21K
|
7.3M
|
53
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
virtuozi
|
11K |
3.8M |
8 |
05/07/22 |
05/07/22 |
General
|
11K
|
3.8M
|
8
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
virtuozi
|
11K |
3.8M |
15 |
05/07/22 |
05/07/22 |
General
|
11K
|
3.8M
|
15
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
virtuozi
|
21K |
7.3M |
9 |
03/07/22 |
03/07/22 |
ASX - By Stock
|
21K
|
7.3M
|
9
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
virtuozi
|
21K |
7.3M |
8 |
02/07/22 |
02/07/22 |
ASX - By Stock
|
21K
|
7.3M
|
8
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
virtuozi
|
21K |
7.3M |
11 |
02/07/22 |
02/07/22 |
ASX - By Stock
|
21K
|
7.3M
|
11
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Zantrene Improves Immune Therapy Treatment of Melanoma
|
|
virtuozi
|
91 |
33K |
19 |
25/06/22 |
25/06/22 |
ASX - By Stock
|
91
|
33K
|
19
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
virtuozi
|
21K |
7.3M |
3 |
16/06/22 |
16/06/22 |
ASX - By Stock
|
21K
|
7.3M
|
3
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
virtuozi
|
11K |
3.8M |
13 |
14/06/22 |
14/06/22 |
General
|
11K
|
3.8M
|
13
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
virtuozi
|
11K |
3.8M |
4 |
20/05/22 |
20/05/22 |
General
|
11K
|
3.8M
|
4
|
|
ASX - By Stock
|
RAC |
Re:
Buyout/buyback strategies
|
|
virtuozi
|
19 |
5.6K |
3 |
20/05/22 |
20/05/22 |
ASX - By Stock
|
19
|
5.6K
|
3
|
|
ASX - By Stock
|
RAC |
Re:
Buyout/buyback strategies
|
|
virtuozi
|
19 |
5.6K |
2 |
20/05/22 |
20/05/22 |
ASX - By Stock
|
19
|
5.6K
|
2
|
|
ASX - By Stock
|
RAC |
Buyout/buyback strategies
|
|
virtuozi
|
19 |
5.6K |
14 |
20/05/22 |
20/05/22 |
ASX - By Stock
|
19
|
5.6K
|
14
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
virtuozi
|
21K |
7.3M |
4 |
19/05/22 |
19/05/22 |
ASX - By Stock
|
21K
|
7.3M
|
4
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
virtuozi
|
21K |
7.3M |
32 |
19/05/22 |
19/05/22 |
ASX - By Stock
|
21K
|
7.3M
|
32
|
|
ASX - By Stock
|
RAC |
Re:
News: RAC Race Oncology Gets Receives Governance Approval For AML EMD & MDS Trial
|
|
virtuozi
|
1 |
769 |
11 |
13/05/22 |
13/05/22 |
ASX - By Stock
|
1
|
769
|
11
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
virtuozi
|
21K |
7.3M |
5 |
11/05/22 |
11/05/22 |
ASX - By Stock
|
21K
|
7.3M
|
5
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
virtuozi
|
21K |
7.3M |
17 |
10/05/22 |
10/05/22 |
ASX - By Stock
|
21K
|
7.3M
|
17
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
virtuozi
|
21K |
7.3M |
12 |
09/05/22 |
09/05/22 |
ASX - By Stock
|
21K
|
7.3M
|
12
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
virtuozi
|
21K |
7.3M |
28 |
25/04/22 |
25/04/22 |
ASX - By Stock
|
21K
|
7.3M
|
28
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Quarterly Activity Report & Appendix 4C
|
|
virtuozi
|
47 |
19K |
8 |
22/04/22 |
22/04/22 |
ASX - By Stock
|
47
|
19K
|
8
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Replacement Announcement - Bonus Options Issued
|
|
virtuozi
|
146 |
47K |
7 |
20/04/22 |
20/04/22 |
ASX - By Stock
|
146
|
47K
|
7
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Replacement Announcement - Bonus Options Issued
|
|
virtuozi
|
146 |
47K |
5 |
20/04/22 |
20/04/22 |
ASX - By Stock
|
146
|
47K
|
5
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Replacement Announcement - Bonus Options Issued
|
|
virtuozi
|
146 |
47K |
2 |
20/04/22 |
20/04/22 |
ASX - By Stock
|
146
|
47K
|
2
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Replacement Announcement - Bonus Options Issued
|
|
virtuozi
|
146 |
47K |
20 |
19/04/22 |
19/04/22 |
ASX - By Stock
|
146
|
47K
|
20
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
virtuozi
|
21K |
7.3M |
6 |
12/04/22 |
12/04/22 |
ASX - By Stock
|
21K
|
7.3M
|
6
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
virtuozi
|
21K |
7.3M |
11 |
07/04/22 |
07/04/22 |
ASX - By Stock
|
21K
|
7.3M
|
11
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race creates Pocari Zantrane® Sportsdrink with Otsuka Pharmaceuticals
|
|
virtuozi
|
10 |
3.7K |
1 |
01/04/22 |
01/04/22 |
ASX - By Stock
|
10
|
3.7K
|
1
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race creates Pocari Zantrane® Sportsdrink with Otsuka Pharmaceuticals
|
|
virtuozi
|
10 |
3.7K |
8 |
01/04/22 |
01/04/22 |
ASX - By Stock
|
10
|
3.7K
|
8
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Zantrene transmutes Lead into Gold
|
|
virtuozi
|
19 |
5.0K |
4 |
01/04/22 |
01/04/22 |
ASX - By Stock
|
19
|
5.0K
|
4
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Zantrene transmutes Lead into Gold
|
|
virtuozi
|
19 |
5.0K |
1 |
01/04/22 |
01/04/22 |
ASX - By Stock
|
19
|
5.0K
|
1
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Zantrene transmutes Lead into Gold
|
|
virtuozi
|
19 |
5.0K |
13 |
01/04/22 |
01/04/22 |
ASX - By Stock
|
19
|
5.0K
|
13
|
|
ASX - By Stock
|
RAC |
Re:
Pillar 1 - FTO (new thread)
|
|
virtuozi
|
2.9K |
1.0M |
3 |
23/03/22 |
23/03/22 |
ASX - By Stock
|
2.9K
|
1.0M
|
3
|
|
ASX - By Stock
|
RAC |
Re:
Pillar 1 - FTO (new thread)
|
|
virtuozi
|
2.9K |
1.0M |
4 |
23/03/22 |
23/03/22 |
ASX - By Stock
|
2.9K
|
1.0M
|
4
|
|
ASX - By Stock
|
RAC |
Re:
Pillar 1 - FTO (new thread)
|
|
virtuozi
|
2.9K |
1.0M |
5 |
23/03/22 |
23/03/22 |
ASX - By Stock
|
2.9K
|
1.0M
|
5
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Zantrene highly effective in EMD AML Mouse Model
|
|
virtuozi
|
115 |
43K |
1 |
19/03/22 |
19/03/22 |
ASX - By Stock
|
115
|
43K
|
1
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Zantrene highly effective in EMD AML Mouse Model
|
|
virtuozi
|
115 |
43K |
3 |
19/03/22 |
19/03/22 |
ASX - By Stock
|
115
|
43K
|
3
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Zantrene highly effective in EMD AML Mouse Model
|
|
virtuozi
|
115 |
43K |
4 |
17/03/22 |
17/03/22 |
ASX - By Stock
|
115
|
43K
|
4
|
|